171 related articles for article (PubMed ID: 37863839)
1. Membranous nephropathy-diagnosis and identification of target antigens.
Sethi S; Fervenza FC
Nephrol Dial Transplant; 2024 Mar; 39(4):600-606. PubMed ID: 37863839
[TBL] [Abstract][Full Text] [Related]
2. Protocadherin 7-Associated Membranous Nephropathy.
Sethi S; Madden B; Debiec H; Morelle J; Charlesworth MC; Gross L; Negron V; Buob D; Chaudhry S; Jadoul M; Fervenza FC; Ronco P
J Am Soc Nephrol; 2021 May; 32(5):1249-1261. PubMed ID: 33833079
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1.
Sethi S; Madden B; Casal Moura M; Nasr SH; Klomjit N; Gross L; Negron V; Charlesworth MC; Alexander MP; Leung N; Specks U; Fervenza FC; Haas M
J Am Soc Nephrol; 2022 May; 33(5):1033-1044. PubMed ID: 35321939
[TBL] [Abstract][Full Text] [Related]
4. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
[TBL] [Abstract][Full Text] [Related]
5. New 'Antigens' in Membranous Nephropathy.
Sethi S
J Am Soc Nephrol; 2021 Feb; 32(2):268-278. PubMed ID: 33380523
[TBL] [Abstract][Full Text] [Related]
6. A Target Antigen-Based Approach to the Classification of Membranous Nephropathy.
Bobart SA; Tehranian S; Sethi S; Alexander MP; Nasr SH; Moura Marta C; Vrana JA; Said S; Giesen CD; Lieske JC; Fervenza FC; De Vriese AS
Mayo Clin Proc; 2021 Mar; 96(3):577-591. PubMed ID: 33673911
[TBL] [Abstract][Full Text] [Related]
7. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.
Sethi S; Debiec H; Madden B; Charlesworth MC; Morelle J; Gross L; Ravindran A; Buob D; Jadoul M; Fervenza FC; Ronco P
Kidney Int; 2020 Jan; 97(1):163-174. PubMed ID: 31901340
[TBL] [Abstract][Full Text] [Related]
8. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
9. Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use.
Sethi S; Casal Moura M; Madden B; Debiec H; Nasr SH; Larsen CP; Gross L; Negron V; Singh RD; Nath KA; Storey AJ; Specks U; Fervenza FC; Ronco P; Caza TN
Kidney Int; 2023 Aug; 104(2):343-352. PubMed ID: 37119877
[TBL] [Abstract][Full Text] [Related]
10. Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry.
Caza TN; Storey AJ; Hassen SI; Herzog C; Edmondson RD; Arthur JM; Kenan DJ; Larsen CP
Kidney Int; 2023 Mar; 103(3):593-606. PubMed ID: 36638888
[TBL] [Abstract][Full Text] [Related]
11. Pediatric membranous nephropathy: In the novel antigens era.
Huang G; Liu F; Yu L; Wang J; Chen J; Mao J
Front Immunol; 2022; 13():962502. PubMed ID: 36016931
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
13. A Proposal for a Serology-Based Approach to Membranous Nephropathy.
De Vriese AS; Glassock RJ; Nath KA; Sethi S; Fervenza FC
J Am Soc Nephrol; 2017 Feb; 28(2):421-430. PubMed ID: 27777266
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
15. Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report.
Santoro D; Debiec H; Longhitano E; Torreggiani M; Barreca A; Vegezzi E; Mazzeo A; Russo M; Piccoli GB; Toscano A; Ronco P
Am J Kidney Dis; 2022 Aug; 80(2):289-294. PubMed ID: 34762973
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy.
Zubidat D; Madden B; Kudose S; Nasr SH; Nardelli L; Fervenza FC; Sethi S
Kidney Int Rep; 2023 Jun; 8(6):1213-1219. PubMed ID: 37284677
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
[TBL] [Abstract][Full Text] [Related]
18. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
19. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].
Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
